Editas Medicine, Inc.EDITNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-11.0%
5Y CAGR-5.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-11.0%/yr
vs +6.5%/yr prior
5Y CAGR
-5.9%/yr
Recent deceleration
Acceleration
-17.4pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $49.90M | -30.7% |
| 2024 | $71.99M | +3.4% |
| 2023 | $69.65M | -1.5% |
| 2022 | $70.70M | -7.2% |
| 2021 | $76.18M | +12.7% |
| 2020 | $67.58M | +4.7% |
| 2019 | $64.56M | +17.4% |
| 2018 | $55.01M | +8.9% |
| 2017 | $50.50M | +9.2% |
| 2016 | $46.26M | - |